ATARA BIOTHERAPEUTICS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $0 as of 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Notes › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2026-05-12
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $0.00.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $0.00.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $0.00.
- 2025-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $0.00.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 |
| 2025-12-31 | $0.00 10-Q · filed 2026-05-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-07 |
| 2023-09-30 | $4.31M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $9.13M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $17.94M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $35.64M 10-K · filed 2024-03-28 |
| 2022-09-30 | $42.24M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $57.18M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $57.69M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $91.12M 10-K · filed 2023-02-08 |
| 2021-09-30 | $55.74M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $69.53M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $64.03M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $64.32M 10-K · filed 2022-02-28 |
| 2020-09-30 | $44.75M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $38.01M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $38.27M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $43.10M 10-K · filed 2021-03-01 |
| 2019-09-30 | $33.69M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $8.90M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $15.77M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $23.11M 10-K · filed 2020-02-27 |
| 2018-09-30 | $39.07M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $72.81M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $69.53M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $12.79M 10-K · filed 2019-02-26 |
| 2017-09-30 | $25.20M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $28.43M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $35.70M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $47.70M 10-K · filed 2018-02-27 |
| 2016-09-30 | $52.17M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $81.08M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $94.38M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $107.94M 10-K · filed 2017-03-09 |
| 2015-09-30 | $163.95M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $41.91M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $41.13M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $25.50M 10-K · filed 2016-03-04 |
| 2014-09-30 | $1.09M 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |